TY - JOUR
T1 - Intrathecal Analgesia
AU - Cohen, Steven P.
AU - Dragovich, Anthony
N1 - Funding Information:
Funded in part by the John P. Murtha Neuroscience and Pain Institute, Johnstown, PA, and the U.S. Department of Defense.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/3
Y1 - 2007/3
N2 - Since the advent of implantable IT drug delivery systems over 25 years ago, numerous advances have been made with regard to system technology, pharmacology, and patient selection. Whereas strong evidence exists for the use of IT therapy for cancer pain, the evidence supporting long-term efficacy in noncancer pain is less convincing. However, in carefully selected patients, combination therapy appears to provide the ideal balance between efficacy and side effects, at least for intermediate-term outcomes. Areas most ripe for future investigation include which pain conditions are most amenable to IT therapy, the long-term efficacy of infusion therapy for noncancer pain, particularly in regard to functional improvement, delineating which drug combinations provide the best balance between efficacy and adverse effects, and conducting preclinical and clinical safety studies on promising analgesics such as ketamine and midazolam.
AB - Since the advent of implantable IT drug delivery systems over 25 years ago, numerous advances have been made with regard to system technology, pharmacology, and patient selection. Whereas strong evidence exists for the use of IT therapy for cancer pain, the evidence supporting long-term efficacy in noncancer pain is less convincing. However, in carefully selected patients, combination therapy appears to provide the ideal balance between efficacy and side effects, at least for intermediate-term outcomes. Areas most ripe for future investigation include which pain conditions are most amenable to IT therapy, the long-term efficacy of infusion therapy for noncancer pain, particularly in regard to functional improvement, delineating which drug combinations provide the best balance between efficacy and adverse effects, and conducting preclinical and clinical safety studies on promising analgesics such as ketamine and midazolam.
UR - http://www.scopus.com/inward/record.url?scp=33847205764&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847205764&partnerID=8YFLogxK
U2 - 10.1016/j.mcna.2006.10.001
DO - 10.1016/j.mcna.2006.10.001
M3 - Review article
C2 - 17321285
AN - SCOPUS:33847205764
SN - 0025-7125
VL - 91
SP - 251
EP - 270
JO - Medical Clinics of North America
JF - Medical Clinics of North America
IS - 2
ER -